TORONTO, ONTARIO –April 19, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 750,000 stock options. 250,000 options were issued to the Company’s CEO, Etienne Grima, in accordance with his employment, and 500,000 options were issued to senior managers of the Company. All options are exercisable at $0.355 per share for five years from the date of grant, vest equally over 18 months at the end of each three month period from the date of grant and are subject to a four month hold period.  The grant of options is subject to the provisions of the Company’s Omnibus Share Compensation Plan, the policies of the TSX Venture Exchange and applicable securities laws.